China Medical System Holdings Limited (the 'Group” or 'CMS”) is pleased to announce that on 11 December 2025, the New Drug ...

The unspoken law of childhood states that the more you spend on a gift, the more likely your kid is to be completely obsessed ...

The door swings open and there it is: the entryway table with a neat stack of magazines, a coat closet that's either ...

Slime bars, escape rooms, and caviar happy hours—your guide to beating the freeze when winter gets brutal. Yes, Boston ...

So, when group ritualized practices consistently deliver intense feelings—whether pleasure, acceptance, or meaning—your brain ...

In a move to streamline regulatory oversight of medical devices, the Central Drugs Standard Control Organisation (CDSCO) has ...

Now that the dust has settled, Netflix stands as the only streamer with scale, brand power, and a profitable model. Hollywood ...

Dinner parties are fun when they are full of laughter and gossip and wine-soaked revelry. But lately those elements have have ...

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI), a clinical-stage biopharmaceutical company developing brain-penetrant therapeutics for central nervous system (CNS) cancers, today announced newly ...

“It turns out the mid-40s is a time of dramatic change, as is the early 60s,” said study senior author Michael Snyder, PhD, ...

Kv7.2/7.3 is a voltage-gated potassium channel whose role is crucial for the regulation of both neuronal excitability and membrane potential. QurAlis is currently planning a Phase 2 clinical trial to ...

And today, Olivia Nuzzi’s greatly anticipated (at least, if you ask any other journalists about it; most of us are unemployed ...